AGIOAgios Pharmaceuticals, Inc.
$36.99-11% 1Y
$36.99
$22.3452 weeks$45.49
Is the price fair?
What AGIO's price assumes
Agios Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 22.5× revenue.
22.5
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.15
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 13.8
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.15
- EV / EBIToperating margin −467%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 13.8
- Market capitalisation59.7 million shares, counted Jul 24, 2026
- $2.21B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks